World's Best Scientists 2026 revealed!
James R. Jett

James R. Jett

D-Index & Metrics

Medicine

D-Index
90
Citations
40641
World Ranking
12020
National Ranking
6162

Overview

James R. Jett is affiliated with the Mayo Clinic in the United States and has contributed extensively to the field of pulmonary and respiratory medicine with a focus on lung cancer research. Their scholarly output spans several interconnected disciplines including oncology, radiology, nuclear medicine, imaging, and cancer research.

Their research topics cover a range of areas, notably:

  • Lung Cancer Treatments and Mutations
  • Lung Cancer Diagnosis and Treatment
  • Radiomics and Machine Learning in Medical Imaging
  • Cancer Genomics and Diagnostics
  • Lung Cancer Research Studies
  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • Medical Imaging Techniques and Applications

James R. Jett's work is published in several venues, prominently featuring the following journals:

  • CHEST Journal
  • Journal of Thoracic Oncology
  • Respirology
  • Journal of Clinical Oncology
  • Cancer

Frequent collaborators in their research include Gerard A. Silvestri, Steven C. Springmeyer, Bruce E. Johnson, Raymond U. Osarogiagbon, and Robert A. Smith.

Recent publications demonstrate an emphasis on clinical applications and diagnostic innovations in lung cancer. Notable papers include:

  • "Knowledge and Practice Patterns Among Pulmonologists for Molecular Biomarker Testing in Advanced Non-small Cell Lung Cancer" (2021, CHEST Journal)
  • "Assessment of Integrated Classifier's Ability to Distinguish Benign From Malignant Lung Nodules" (2020, CHEST Journal)
  • "The Intersection of Lung Cancer Screening, Radiomics, and Artificial Intelligence: Can One Scan Really Predict the Future Development of Lung Cancer?" (2023, Journal of Clinical Oncology)
  • "Managing Lung Nodules Using Telemedicine and Molecular Biomarkers During the COVID-19 Pandemic" (2020, CHEST Journal)
  • "The American Cancer Society National Lung Cancer Roundtable strategic plan: Advancing comprehensive biomarker testing in non-small cell lung cancer" (2024, Cancer)

Their expertise is situated primarily in medicine, with 39 publications attributed to this main field of study. Subfields include pulmonary and respiratory medicine, oncology, radiology and imaging techniques, cancer research, and critical care medicine.

Best Publications

  • International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma

    William D Travis;Elisabeth Brambilla;Masayuki Noguchi;Andrew G Nicholson

  • Guidelines for Management of Small Pulmonary Nodules Detected on CT Scans: A Statement from the Fleischner Society

    Heber MacMahon;John H. M. Austin;Gordon Gamsu;Christian J. Herold

  • The IASLC Lung Cancer Staging Project: Proposals for the Revisions of the T Descriptors in the Forthcoming Eighth Edition of the TNM Classification for Lung Cancer

    Ramón Rami-Porta;David Ball;John Crowley;Dorothy J. Giroux

  • Benefits and Harms of CT Screening for Lung Cancer: A Systematic Review

    Peter B. Bach;Joshua N. Mirkin;Thomas K. Oliver;Christopher G. Azzoli

  • The national lung screening trial: Overview and study design

    Constantine A. Gatsonis;Denise R. Aberle;Christine D. Berg;William C. Black

  • Screening for lung cancer with low-dose spiral computed tomography.

    Stephen J. Swensen;James R. Jett;Jeff A. Sloan;David E. Midthun

  • Lung cancer screening with CT: Mayo Clinic experience

    Stephen J. Swensen;James R. Jett;Thomas E. Hartman;David E. Midthun

  • CT Screening for Lung Cancer: Five-year Prospective Experience

    Stephen J. Swensen;James R. Jett;Thomas E. Hartman;David E. Midthun

  • Non-small-cell lung cancer

    Peter Goldstraw;David Ball;James R Jett;Thierry Le Chevalier

  • Phase III Trial of Maintenance Gefitinib or Placebo After Concurrent Chemoradiotherapy and Docetaxel Consolidation in Inoperable Stage III Non–Small-Cell Lung Cancer: SWOG S0023

    Karen Kelly;Kari Chansky;Laurie E. Gaspar;Kathy S. Albain

  • Computed tomography screening and lung cancer outcomes.

    Peter B. Bach;James R. Jett;Ugo Pastorino;Melvyn S. Tockman

  • The American Association for Thoracic Surgery guidelines for lung cancer screening using low-dose computed tomography scans for lung cancer survivors and other high-risk groups

    Michael T. Jaklitsch;Francine L. Jacobson;John H.M. Austin;John K. Field

  • International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society: international multidisciplinary classification of lung adenocarcinoma: executive summary.

    William D. Travis;Elisabeth Brambilla;Masayuki Noguchi;Andrew G. Nicholson

  • Phase III trial of irinotecan/cisplatin compared with etoposide/cisplatin in extensive-stage small-cell lung cancer: clinical and pharmacogenomic results from SWOG S0124

    Primo N. Lara;Ronald Natale;John Crowley;Heinz Josef Lenz

  • IASLC肺癌病期分類プロジェクト:肺癌TNM分類次版(第7版)におけるT desriptor修正の提案

    Rami-Porta R;Ball D;Crowley J;Giroux Dj

  • Clinical features of 5,628 primary lung cancer patients: experience at Mayo Clinic from 1997 to 2003.

    Ping Yang;Mark S. Allen;Marie C. Aubry;Jason A. Wampfler

  • Treatment of small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.

    James R. Jett;Steven E. Schild;Kenneth A. Kesler;Gregory P. Kalemkerian

  • Five-year lung cancer screening experience: CT appearance, growth rate, location, and histologic features of 61 lung cancers.

    Rebecca M. Lindell;Thomas E. Hartman;Stephen J. Swensen;James R. Jett

  • Gefitinib Versus Placebo in Completely Resected Non–Small-Cell Lung Cancer: Results of the NCIC CTG BR19 Study

    Glenwood D. Goss;Chris O'Callaghan;Ian Lorimer;Ming Sound Tsao

  • A new immunodeficiency disorder in humans involving NK cells.

    John C. Roder;John C. Roder;Tina Haliotis;Tina Haliotis;Margareta Klein;Margareta Klein;Stefan Korec

Frequent Co-Authors

Alex A. Adjei
Alex A. Adjei Cleveland Clinic
Steven E. Schild
Steven E. Schild Mayo Clinic
Jeff A. Sloan
Jeff A. Sloan Mayo Clinic
William D. Travis
William D. Travis Memorial Sloan Kettering Cancer Center
David R. Gandara
David R. Gandara University of California, Davis
Nagahiro Saijo
Nagahiro Saijo AstraZeneca (United Kingdom)
Lance A. Liotta
Lance A. Liotta George Mason University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Medicine in the USA can open doors to a diverse range of online degrees and career opportunities in healthcare. Many students look for flexible, affordable programs that allow them to advance their skills while balancing other commitments.

If you want to move into healthcare management, consider exploring mha degree cost to find an affordable master’s in healthcare administration. This degree prepares you for leadership roles in hospitals, clinics, and medical organizations.

Nurses looking to reach the highest level of clinical practice may benefit from the cheapest dnp program. Earning a Doctor of Nursing Practice can lead to advanced practice, leadership, and teaching roles.

Pharmacy also offers online options. The online pharmd gives prospective pharmacists an accessible route to licensure and advanced pharmacy practice.

Health information management is crucial in today’s data-driven healthcare landscape. If you’re interested in this area, check out a bachelor of health information management online for a flexible path toward careers in medical data, health IT, and administration.

Best Scientists Citing James R. Jett

Trending Scientists

Recently Published Articles